Jennifer Knister is a bioprocess engineer with over 6 years of experience in the downstream process development of mAbs, antibody fragments, and other proteins. Jennifer completed her ...

GE HealthCare is launching a new imaging research collaboration with the University of California, San Francisco, aimed at ...

The therapy, dubbed OST-HER2, uses a HER2-bioengineered form of the bacteria Listeria monocytogenes to trigger an immune ...

Neumora Therapeutics’ phase 3 fail was worse than analysts feared. | Neumora Therapeutics’ phase 3 fail was worse than ...

The FDA is elevating a recall from Philips related to one of its wearable outpatient heart monitors, used to help detect ...

A month after halting dosing in two of the three treatment arms of a phase 2 trial of its pulmonary arterial hypertension ...

Yesterday, spots of pink could be spotted on the streets of San Francisco, and it wasn’t a coincidence. Members of the ...

And while Wood said the pharma still isn’t interested in joining the overcrowded obesity landscape, GSK is considering ways ...

Daiichi Sankyo is turning to the German city of Heidelberg for help developing antibodies. The Japanese pharma giant is ...

N-Power Medicine, a tech firm with a clinical trial platform for capturing real-world patient data, has acquired precision ...

Welcome to Day 2 of the J.P. Morgan Healthcare Conference 2025 in San Francisco. | Welcome to Day 2 of the J.P. Morgan ...

After spending the past year extending its portfolio of continuous glucose monitors to include people who may not have ...